ImportRefusal LogoImportRefusal

Progrand Pharmaceutical Corporation Limited

⚠️ Moderate Risk

FEI: 3003394812 • Hong Kong • HONG KONG

FEI

FEI Number

3003394812

📍

Location

Hong Kong

🇭🇰

Country

HONG KONG
🏢

Address

Flat C 7 F Sunview Indst Build No 3 On, , Hong Kong, , Hong Kong

Moderate Risk

FDA Import Risk Assessment

40.3
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

1
Total Refusals
1
Unique Violations
9/18/2004
Latest Refusal
9/18/2004
Earliest Refusal

Score Breakdown

Violation Severity
90.0×40%
Refusal Volume
11.2×30%
Recency
0.0×20%
Frequency
10.0×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

751×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

Refusal History

DateProductViolationsDivision
9/18/2004
54FCT99HERBALS & BOTANICALS (NOT TEAS), N.E.C.
75UNAPPROVED
Los Angeles District Office (LOS-DO)

Frequently Asked Questions

What is Progrand Pharmaceutical Corporation Limited's FDA import refusal history?

Progrand Pharmaceutical Corporation Limited (FEI: 3003394812) has 1 FDA import refusal record(s) in our database, spanning from 9/18/2004 to 9/18/2004.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Progrand Pharmaceutical Corporation Limited's FEI number is 3003394812.

What types of violations has Progrand Pharmaceutical Corporation Limited received?

Progrand Pharmaceutical Corporation Limited has been cited for 1 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Progrand Pharmaceutical Corporation Limited come from?

All FDA import refusal data for Progrand Pharmaceutical Corporation Limited is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.